Market Research Logo

Europe Sickle Cell Anemia Market and Competitive Landscape – 2017

Europe Sickle Cell Anemia Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Sickle Cell Anemia Market and Competitive Landscape – 2017, provides comprehensive insights into Sickle Cell Anemia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Sickle Cell Anemia market size and drug sales. This research also provides insights into Sickle Cell Anemia epidemiology and late stage pipeline.
The report is classified into nine sections – Sickle Cell Anemia overview with definitions, symptoms, etiology, diagnosis, treatment options; Sickle Cell Anemia pipeline insights covering late stage clinical trials pipeline; Sickle Cell Anemia prevalence trends by countries; Sickle Cell Anemia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

  • Sickle Cell Anemia pipeline: Find out the drugs in clinical trials for Sickle Cell Anemia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Sickle Cell Anemia epidemiology: Find out the prevalence of Sickle Cell Anemia by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Sickle Cell Anemia products: Identify key products marketed and prescribed for Sickle Cell Anemia by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Sickle Cell Anemia market size: Find out the market size for Sickle Cell Anemia drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Sickle Cell Anemia drug sales: Find out the sales of Sickle Cell Anemia drugs by countries – Europe, Germany, France, Italy, Spain, UK
  • Sickle Cell Anemia drugs sales forecast: Sales forecast for Sickle Cell Anemia drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Sickle Cell Anemia market share analysis: Find out the market shares of Sickle Cell Anemia drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Sickle Cell Anemia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Sickle Cell Anemia market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Sickle Cell Anemia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Sickle Cell Anemia: Disease Overview
1.1. Sickle Cell Anemia Symptoms
1.2. Sickle Cell Anemia Etiology
1.3. Sickle Cell Anemia Diagnosis
1.4. Sickle Cell Anemia Treatment Options
2. Sickle Cell Anemia Pipeline Insights
2.1. Sickle Cell Anemia Phase 3 Clinical Trials
2.2. Sickle Cell Anemia Phase 2 Clinical Trials
2.3. Sickle Cell Anemia Phase 1 Clinical Trials
3. Sickle Cell Anemia Epidemiology Analysis
4. Germany Sickle Cell Anemia Market Insights
4.1. Marketed Products for Sickle Cell Anemia in Germany
4.2. Germany Sickle Cell Anemia Market Size & Forecast
4.3. Germany Sickle Cell Anemia Product Sales Forecast
4.4. Germany Sickle Cell Anemia Market Share Analysis
5. France Sickle Cell Anemia Market Insights
5.1. Marketed Products for Sickle Cell Anemia in France
5.2. France Sickle Cell Anemia Market Size & Forecast
5.3. France Sickle Cell Anemia Product Sales Forecast
5.4. France Sickle Cell Anemia Market Share Analysis
6. Italy Sickle Cell Anemia Market Insights
6.1. Marketed Products for Sickle Cell Anemia in Italy
6.2. Italy Sickle Cell Anemia Market Size & Forecast
6.3. Italy Sickle Cell Anemia Product Sales Forecast
6.4. Italy Sickle Cell Anemia Market Share Analysis
7. Spain Sickle Cell Anemia Market Insights
7.1. Marketed Products for Sickle Cell Anemia in Spain
7.2. Spain Sickle Cell Anemia Market Size & Forecast
7.3. Spain Sickle Cell Anemia Product Sales Forecast
7.4. Spain Sickle Cell Anemia Market Share Analysis
8. UK Sickle Cell Anemia Market Insights
8.1. Marketed Products for Sickle Cell Anemia in UK
8.2. UK Sickle Cell Anemia Market Size & Forecast
8.3. UK Sickle Cell Anemia Product Sales Forecast
8.4. UK Sickle Cell Anemia Market Share Analysis
9. Europe Sickle Cell Anemia Market Insights
9.1. Europe Sickle Cell Anemia Market Size & Forecast
9.2. Europe Sickle Cell Anemia Product Sales Forecast
9.3. Europe Sickle Cell Anemia Market Share Analysis
10. Research Methodology
LIST OF TABLES
Table 1: Sickle Cell Anemia Phase 3 Clinical Trials, Global, 2017
Table 2: Sickle Cell Anemia Phase 2 Clinical Trials, Global, 2017
Table 3: Sickle Cell Anemia Phase 1 Clinical Trials, Global, 2017
Table 4: Sickle Cell Anemia Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Sickle Cell Anemia in Germany, 2017
Table 6: Germany Sickle Cell Anemia Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Sickle Cell Anemia Product Sales ($mn), 2012 - 2021
Table 8: Germany Sickle Cell Anemia Market Trends, 2012 - 2021
Table 9: Marketed Products for Sickle Cell Anemia in France, 2017
Table 10: France Sickle Cell Anemia Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Sickle Cell Anemia Product Sales ($mn), 2012 - 2021
Table 12: France Sickle Cell Anemia Market Trends, 2012 - 2021
Table 13: Marketed Products for Sickle Cell Anemia in Italy, 2017
Table 14: Italy Sickle Cell Anemia Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Sickle Cell Anemia Product Sales ($mn), 2012 - 2021
Table 16: Italy Sickle Cell Anemia Market Trends, 2012 - 2021
Table 17: Marketed Products for Sickle Cell Anemia in Spain, 2017
Table 18: Spain Sickle Cell Anemia Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Sickle Cell Anemia Product Sales ($mn), 2012 - 2021
Table 20: Spain Sickle Cell Anemia Market Trends, 2012 - 2021
Table 21: Marketed Products for Sickle Cell Anemia in UK, 2017
Table 22: UK Sickle Cell Anemia Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Sickle Cell Anemia Product Sales ($mn), 2012 - 2021
Table 24: UK Sickle Cell Anemia Market Trends, 2012 - 2021
Table 25: Europe Sickle Cell Anemia Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Sickle Cell Anemia Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Sickle Cell Anemia Pipeline by Phase (%), Global, 2017
Figure 2: Sickle Cell Anemia Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Sickle Cell Anemia Market Size ($mn), 2012 - 2021
Figure 4: Germany Sickle Cell Anemia Product Sales ($mn), 2012 - 2021
Figure 5: Germany Sickle Cell Anemia Market Share by Products (%), 2016
Figure 6: Germany Sickle Cell Anemia Market - Future Market Share (%), 2021
Figure 7: France Sickle Cell Anemia Market Size ($mn), 2012 - 2021
Figure 8: France Sickle Cell Anemia Product Sales ($mn), 2012 - 2021
Figure 9: France Sickle Cell Anemia Market Share by Products (%), 2016
Figure 10: France Sickle Cell Anemia Market - Future Market Share (%), 2021
Figure 11: Italy Sickle Cell Anemia Market Size ($mn), 2012 - 2021
Figure 12: Italy Sickle Cell Anemia Product Sales ($mn), 2012 - 2021
Figure 13: Italy Sickle Cell Anemia Market Share by Products (%), 2016
Figure 14: Italy Sickle Cell Anemia Market - Future Market Share (%), 2021
Figure 15: Spain Sickle Cell Anemia Market Size ($mn), 2012 - 2021
Figure 16: Spain Sickle Cell Anemia Product Sales ($mn), 2012 - 2021
Figure 17: Spain Sickle Cell Anemia Market Share by Products (%), 2016
Figure 18: Spain Sickle Cell Anemia Market - Future Market Share (%), 2021
Figure 19: UK Sickle Cell Anemia Market Size ($mn), 2012 - 2021
Figure 20: UK Sickle Cell Anemia Product Sales ($mn), 2012 - 2021
Figure 21: UK Sickle Cell Anemia Market Share by Products (%), 2016
Figure 22: UK Sickle Cell Anemia Market - Future Market Share (%), 2021
Figure 23: Europe Sickle Cell Anemia Market Size ($mn), 2012 - 2021
Figure 24: Europe Sickle Cell Anemia Product Sales ($mn), 2012 - 2021
Figure 25: Europe Sickle Cell Anemia Market Share by Products (%), 2016
Figure 26: Europe Sickle Cell Anemia Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report